Showing results (51-60 of 260) with videos related to
Sort By:
Pageof 26
European Urology|January 1, 1984
Mucinous adenocarcinoma of the renal pelvisV Mirone, D Prezioso, S Palombini, et al.Biologics : Targets & Therapy|August 27, 2009
Efalizumab-induced severe thrombocytopenia can be resolvedFrancesca Prignano, F Zanieri, S Mokhtarzadeh, et al.Dermatologic Therapy|July 8, 2009
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case reportF Prignano, F Zanieri, S Milani, et al.International Journal of Dermatology|May 1, 1990
Proteoglycans in so-called celluliteT Lotti, I Ghersetich, C Grappone, et al.Journal D'Urologie|January 1, 1996
[Value of high-dose pure FSH in the treatment of idiopathic male infertility]F Iacono, S Barra, L Montano, et al.Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 9, 2010
Exacerbation of allergic contact dermatitis during immunosuppression with cyclosporine AF Prignano, V Bonciolini, D Bonciani, et al.Annals of the New York Academy of Sciences|May 19, 2000
POMC and fibroblast biologyT Lotti, P Teofoli, B Bianchi, et al.Urologia Internationalis|June 2, 1998
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 31, 2009
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbiditiesF Prignano, L Pescitelli, F Ricceri, et al.International Journal of Immunopathology and Pharmacology|June 10, 2009
Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasisF Prignano, F Ricceri, B Bianchi, et al.Pageof 26